"....Professor Young suggested that the National Health and Medical
Research Council (NHMRC) could prioritise funding for specific cancers.
“The NHMRC needs to take a more strategic view as to where they place
the funds, and where they create the incentive for specific cancers,” he
said.
He said this would encourage researchers to study the
underrepresented cancers. “In my view, researchers go to where they can
get the money and not necessarily to where the problems are, and I think
this paper proves that,” he said...."
Dr Annette Katelaris:
"... the National Cancer Institute in the United States is planning to create a “
cross-disease panel” that will establish priorities for funding and coordination of clinical trials."
Comment
 |
|
|
|
|
|
Jane McCredie: Answering the tricky question
FULL STORY.
|
|
|
|
|
Nick Graves: The real cost of research cuts
FULL STORY. |
|
|
|
| |
|
|
Dr Annette Katelaris: Matching funding to need
FULL STORY. |
|
|
